Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 6, 1999, Pages 1162-1167

  Volovitz, Benjamin ^a,b   Tabachnik, Elvan ^c   Nussinovitch, Moshe ^b   Shtaif, Biana ^b   Blau, Hanna ^a   Gil Ad, Irit ^b   Weizman, Abraham ^b   Varsano, Itzhak ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c KAPLAN HOSPITAL   (Israel)

Author keywords

Asthma; Children; Leukotriene modifiers; Leukotrienes; Montelukast; Nasal washes

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; EOSINOPHIL CATIONIC PROTEIN; LEUKOTRIENE C4; MONTELUKAST;

ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; ICOSANOID METABOLISM; INHALATIONAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; NOSE MUCUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY EPITHELIUM; TISSUE LEVEL; TREATMENT OUTCOME;

EID: 0033459580     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70008-4     Document Type: Article

References (34)

1. 4 in man. Biochem Biophys Res Commun 1985;130:214-20.
2. 2. Drazen JM, Israel E. Asthma: a solution of half the puzzle? Am Rev Resp Dis 1991;144:743-4.
3. 4 in children with atopic asthma. Pediatr Res 1991;29:455-9.
4. 4. Hui KP, Taylor JK, Taylor GW, Rubin P, Kesterson J, Barnes NC, et al. Effect of a 5-hypoxygenase inhibitor on leukotriene generation and airway response after allergen challenge in asthmatic patients. Thorax 1991;46:184-9.
5. 5. Diamant Z, Timmers MC, ver der Veen H, Friedman BS, De-Smet M, Depre M, et al. The effect of MK-0591, a novel 5-hypoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol 1995;95:42-51.
6. 4 in patients with asthma: effect of airways reactivity and sodium cromoglycate. Am Rev Resp Dis 1991;143:1322-8.
7. 4 plasma levels in adult asthmatic patients with variable disease severity. Allergy 1997;52:589-9 2.
8. 8. Creticos PS, Peters SP, Adkinson F Jr, Naclerio RM, Hayes ED, Norman PS, et al. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 1984;310:1626-3 0.
9. 9. Lam S, Chan H, LeRiche JC, Chan-Yeung M, Salari H. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988;81:711-7.
10. 10. Israel E, Rubin P, Kemp JP, Grossman J, Pierson W, Siegal SC, et al. The effect of inhibition of 5-hypoxygenase by zieluton in mild to moderate asthma. Ann Intern Med 1993;119:1059-6 6.
11. 4 after exercise challenge in children with asthma. J Allergy Clin Immunol 1992;89:1111-9.
12. 4 during clinical course of bronchial asthma and the effect of oral prednisolone. Chest 1994;105:1033-41.
13. 4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989;84:19-26.
14. 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 1990;142:112-9.
15. 4 in the human respiratory tract during viral infection. J Pediatr 1988;112:218-22.
16. 16. Volovitz B, Welliver R, DeCastro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory synctial virus: role in obstructive airway disease. Pediatr Res 1988;24:504-6.
17. 4) release in respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children. J Allergy Clin Immunol 1988;82:414-8.
18. 4 and a uteroglobin-like protein in nasal and tracheobronchial mucosa in children: implication in acute respiratory illnesses. Int Arch Allergy Appl Immunol 1988;86:420-5.
19. 19. Sedgwick JB, Calhoun WJ, Gleich GJ, Kita H, Abrams JS, Schwartz LB, et al. Immediate and late airway response of allergic rhinitis patients to santigen challenge: characterization of eosinophil and mast cell mediators. Am Rev Resp Dis 1991;144:1274-81.
20. 4 in children with atopic asthma, I: plasma levels in acute asthma. Acta Paediatr Jpn 1989;31:286-94.
21. 21. Brodsky I, Faden H, Bernstein J, Stanievich J, DeCastro G, Volovitz B, et al. Arachidonic acid metabolites in middle ear effusions of children. Oto Rhinol Laryngol 1991;100:589-92.
22. 22. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist in the treatment of chronic asthma. Arch Intern Med 1998;158:1213-20.
23. 23. Knorr B, Matz J, Bernstein JA, Ngugen H, Seidenberg BC, Reiss TF, et al. Montelukast for chronic asthma in 6-to 14-year-old children: a randomized, double-blind trial. JAMA 1998;279:1181-6.
24. 24. BMDP statistical software. Dixon WJ, editor. Los Angeles: University of Californian Press; 1990.
25. 25. Picado C, Ramis I, Rosello J, Prat J, Bulbena O, Plaza V, et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992;145:65-9.
26. 26. Naclerio RM, Meier HL, Kagey-Sobotka, Adkinson NF, Meyers DA, Norman PS, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:587-602.
27. 27. Weller PF, Lee CW, Foster DW, Curey EJ, Austen KF, Lewis RA, et al. Generation and metabolism of 5-lipooxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci U S A 1983;80:7626-30.
28. 28. Kumlin M, Dahlen SE. Characteristics of formation and further metabolism of leukotrienes in the chopped human lung. Biochem Biophys Acta 1990;1044:201-10.
29. 4 and granulocytic infiltration into asthmatic airways. Lancet 1992;341:989-90.
30. 4 in humans. Am Rev Respir Dis 1985;131:368-72.
31. 4 by human eosinophils. J Immunol 1987;138:532-8.
32. 4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans. Clin Allergy 1986;16:289-97.
33. 33. Schwartzberg SB, Shelov SP, van Praag D. Blood leukotriene levels during the acute asthma attack in children. Prostaglandins Leukotrienes Med 1987;26:143-55
34. 34. Ramis I, Catafau JR, Serra J, Bulbena O, Picado C, Gelpi E. In vivo release of 15-HETE and other arachidonic acid metabolites in nasal secretions during early allergic reactions. Prostaglandins 1991;42:411-20.